Specifically, Ma et al. showed that hyperactive mTOR signaling correlates with increased Notch signaling in poorly differentiated breast cancers and is also associated with a poor clinical outcome in women with mTOR/Notch over expressing tumors (113). This evidence concerns the gene MTOR and breast cancer.